CRIS Current Research Information System

SANTUCCI, MARIA ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.577
EU - Europa 1.927
AS - Asia 812
AF - Africa 131
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.570
GB - Regno Unito 580
VN - Vietnam 351
SE - Svezia 285
CN - Cina 274
DE - Germania 252
IT - Italia 201
UA - Ucraina 192
IN - India 98
IE - Irlanda 91
RU - Federazione Russa 89
FR - Francia 77
TG - Togo 54
ZA - Sudafrica 44
EE - Estonia 42
CH - Svizzera 31
SG - Singapore 26
JO - Giordania 24
BG - Bulgaria 20
NG - Nigeria 15
BE - Belgio 13
FI - Finlandia 13
JP - Giappone 12
GR - Grecia 11
IR - Iran 11
SC - Seychelles 10
CA - Canada 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
NL - Olanda 6
RO - Romania 6
HR - Croazia 4
ID - Indonesia 4
UZ - Uzbekistan 4
AU - Australia 3
BR - Brasile 3
PL - Polonia 3
CL - Cile 2
KR - Corea 2
PE - Perù 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
EG - Egitto 1
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 5.459
Salva come PNG Salva come JPEG
Città #
Southend 514
Chandler 317
Fairfield 315
Ashburn 203
Wilmington 173
Seattle 161
Dong Ket 160
Woodbridge 152
Houston 138
Jacksonville 136
Ann Arbor 126
Princeton 111
Cambridge 107
Dublin 90
Nanjing 57
Lomé 54
Westminster 53
Padova 52
Berlin 41
New York 34
Beijing 30
Bern 28
Bologna 27
Jinan 25
Amman 24
Shenyang 24
Medford 20
Mülheim 20
Sofia 20
Falls Church 19
Hebei 19
Milan 19
San Diego 19
Saint Petersburg 18
Changsha 17
Singapore 17
Boardman 16
Abeokuta 15
Nanchang 15
Redmond 15
Verona 15
Brussels 13
Tianjin 13
Helsinki 12
Des Moines 11
Tokyo 11
Taizhou 10
Turin 10
Mahé 9
Dearborn 8
Hangzhou 8
Kuban 8
Norwalk 8
Bühl 7
Rome 7
Zhengzhou 7
Abidjan 6
Bremen 6
Florence 6
Guangzhou 6
Jiaxing 6
Ningbo 6
Phoenix 6
Toronto 6
Andover 5
Frankfurt am Main 5
Lanzhou 5
Washington 5
Jakarta 4
Kunming 4
Los Angeles 4
Zanjan 4
Fremont 3
Fuzhou 3
Lausanne 3
Mountain View 3
Olalla 3
San Francisco 3
San Mateo 3
Siena 3
Ardabil 2
Bengaluru 2
Chimbote 2
Clearwater 2
Forlì 2
Gilze 2
Groningen 2
Latina 2
Leawood 2
London 2
Plauen 2
Redwood City 2
San Venanzo 2
São Paulo 2
Taiyuan 2
Warsaw 2
Aigaleo 1
Albany 1
Arraial d'Ajuda 1
Atlanta 1
Totale 3.702
Salva come PNG Salva come JPEG
Nome #
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia 198
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 194
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib 183
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. 167
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia 157
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia 157
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia 155
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 152
CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 147
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 132
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. 129
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 126
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. 121
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 115
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 114
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 110
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 110
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 108
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. 107
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 107
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 106
Tyrosine kinase inhibotr STI571 (Imatinib) cooperates with wild type p53 on k562 cell line to enhance its pro-apoptotic effets 106
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 105
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 102
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias 101
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 101
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 98
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 98
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia 97
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene 96
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 93
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein 91
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 91
P53 and beta catenin cross-talk in the medulloblastoma cell line radiosensitivity 89
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 88
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 88
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells 84
FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia 83
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 81
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 78
GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) 77
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) 76
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 75
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 74
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia 74
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 71
P210 BCR-ABL TYROSINE KINASE INHIBITS APOPTOTIC CELL DEATH THROUGH MULTIPLE PATHWAYS PREVENTING EARLY MITOCHONDRIAL ACTIVATION 70
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE 69
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia. 64
Idetification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. 60
The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics 48
La tirosin-cinasi del prodotto p210 di bcr-abl sopprime l'apoptosi mitocondrio dipendente 47
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 46
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction. 44
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3 sigma case. 2
Totale 5.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.453 228 42 24 94 136 128 180 194 179 101 49 98
2020/2021881 155 64 27 44 11 50 10 63 74 37 56 290
2021/20221.118 190 28 86 81 87 58 27 58 31 72 210 190
2022/20231.189 133 205 71 145 82 107 25 51 189 32 85 64
2023/2024304 18 49 16 49 19 79 22 14 8 13 8 9
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 5.562